These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8982070)

  • 1. Reexamining interaction of the SH2 domains of SYP and GAP with insulin and IGF-1 receptors in the two-hybrid system.
    Lamothe B; Bucchini D; Jami J; Joshi RL
    Gene; 1996 Dec; 182(1-2):77-80. PubMed ID: 8982070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of the insulin-like growth factor I receptor binding sites for the SH2 domain proteins p85, Syp, and GTPase activating protein.
    Seely BL; Reichart DR; Staubs PA; Jhun BH; Hsu D; Maegawa H; Milarski KL; Saltiel AR; Olefsky JM
    J Biol Chem; 1995 Aug; 270(32):19151-7. PubMed ID: 7642582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of p85 subunit of PI 3-kinase with insulin and IGF-1 receptors analysed by using the two-hybrid system.
    Lamothe B; Bucchini D; Jami J; Joshi RL
    FEBS Lett; 1995 Oct; 373(1):51-5. PubMed ID: 7589433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of the insulin receptor binding sites for the SH2 domain proteins p85, Syp, and GAP.
    Staubs PA; Reichart DR; Saltiel AR; Milarski KL; Maegawa H; Berhanu P; Olefsky JM; Seely BL
    J Biol Chem; 1994 Nov; 269(44):27186-92. PubMed ID: 7525547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of SH2-containing protein tyrosine phosphatase 2 with the insulin receptor and the insulin-like growth factor-I receptor: studies of the domains involved using the yeast two-hybrid system.
    Rocchi S; Tartare-Deckert S; Sawka-Verhelle D; Gamha A; van Obberghen E
    Endocrinology; 1996 Nov; 137(11):4944-52. PubMed ID: 8895367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-1 (IGF-1) receptor-insulin receptor substrate complexes in the uterus. Altered signaling response to estradiol in the IGF-1(m/m) mouse.
    Richards RG; Walker MP; Sebastian J; DiAugustine RP
    J Biol Chem; 1998 May; 273(19):11962-9. PubMed ID: 9565625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 60-kilodalton protein in rat hepatoma cells overexpressing insulin receptor was tyrosine phosphorylated and associated with Syp, phophatidylinositol 3-kinase, and Grb2 in an insulin-dependent manner.
    Zhang-Sun G; Yang C; Viallet J; Feng G; Bergeron JJ; Posner BI
    Endocrinology; 1996 Jul; 137(7):2649-58. PubMed ID: 8770882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of the molecular weight 85K regulatory subunit of the phosphatidylinositol 3-kinase with the insulin receptor and the insulin-like growth factor-1 (IGF- I) receptor: comparative study using the yeast two-hybrid system.
    Tartare-Deckert S; Murdaca J; Sawka-Verhelle D; Holt KH; Pessin JE; Van Obberghen E
    Endocrinology; 1996 Mar; 137(3):1019-24. PubMed ID: 8603569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and cloning of a 58/53-kDa substrate of the insulin receptor tyrosine kinase.
    Yeh TC; Ogawa W; Danielsen AG; Roth RA
    J Biol Chem; 1996 Feb; 271(6):2921-8. PubMed ID: 8621681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential involvement of FRS2 in insulin signaling.
    Delahaye L; Rocchi S; Van Obberghen E
    Endocrinology; 2000 Feb; 141(2):621-8. PubMed ID: 10650943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early signaling events triggered by peroxovanadium [bpV(phen)] are insulin receptor kinase (IRK)-dependent: specificity of inhibition of IRK-associated protein tyrosine phosphatase(s) by bpV(phen).
    Band CJ; Posner BI; Dumas V; Contreres JO
    Mol Endocrinol; 1997 Dec; 11(13):1899-910. PubMed ID: 9415395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatidylinositol 3'-kinase associates with an insulin receptor substrate-1 serine kinase distinct from its intrinsic serine kinase.
    Cengel KA; Kason RE; Freund GG
    Biochem J; 1998 Oct; 335 ( Pt 2)(Pt 2):397-404. PubMed ID: 9761740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The insulin receptor substrate 1 associates with the SH2-containing phosphotyrosine phosphatase Syp.
    Kuhné MR; Pawson T; Lienhard GE; Feng GS
    J Biol Chem; 1993 Jun; 268(16):11479-81. PubMed ID: 8505282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The alphaVbeta3 integrin regulates insulin-like growth factor I (IGF-I) receptor phosphorylation by altering the rate of recruitment of the Src-homology 2-containing phosphotyrosine phosphatase-2 to the activated IGF-I receptor.
    Maile LA; Clemmons DR
    Endocrinology; 2002 Nov; 143(11):4259-64. PubMed ID: 12399420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4.
    Marengère LE; Waterhouse P; Duncan GS; Mittrücker HW; Feng GS; Mak TW
    Science; 1996 May; 272(5265):1170-3. PubMed ID: 8638161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of wild type and dominant-negative p55PIK regulatory subunit of phosphatidylinositol 3-kinase with insulin-like growth factor-1 signaling proteins.
    Mothe I; Delahaye L; Filloux C; Pons S; White MF; Van Obberghen E
    Mol Endocrinol; 1997 Dec; 11(13):1911-23. PubMed ID: 9415396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of distinct signalling complexes involving phosphatidylinositol 3-kinase activity with stimulation of epidermal growth factor or insulin-like growth factor-I in human skin fibroblasts.
    Takahashi Y; Akanuma Y; Yazaki Y; Kadowaki T
    J Cell Physiol; 1999 Jan; 178(1):69-75. PubMed ID: 9886492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a putative Syp substrate, the PDGF beta receptor.
    Klinghoffer RA; Kazlauskas A
    J Biol Chem; 1995 Sep; 270(38):22208-17. PubMed ID: 7545675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor-binding, tyrosine phosphorylation and chromosome localization of the mouse SH2-containing phosphotyrosine phosphatase Syp.
    Feng GS; Shen R; Heng HH; Tsui LC; Kazlauskas A; Pawson T
    Oncogene; 1994 Jun; 9(6):1545-50. PubMed ID: 8183548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged vs transient roles for early cell cycle signaling components.
    Rose DW; Xiao S; Pillay TS; Kolch W; Olefsky JM
    Oncogene; 1998 Aug; 17(7):889-99. PubMed ID: 9780005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.